ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag big pharma culture disease medicine

Career Supplement | Big Makeover for Big Pharma
Alison McCook | Jun 19, 2005 | 10 min read
Since the New York City life science technology-consulting firm Intrasphere Technologies opened an office in India, Samuel Goldman, cofounder and chief technology officer, says he works fairly bizarre hours, scheduling 6:00 A.M. meetings on a "regular basis."
Best Places to Work Industry 2013
The Scientist | Jun 1, 2013 | 6 min read
Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
The Profits of Nonprofit
Megan Scudellari | Jan 1, 2011 | 7 min read
The surprising results when drug development and altruism collide
One hand holding the other, depicting pain in the joints
A Bacterial Culprit for Rheumatoid Arthritis
Hannah Thomasy, PhD, Drug Discovery News | Apr 27, 2023 | 4 min read
Scientists identified a species of Subdoligranulum that may drive disease.
A rendering of a human brain in blue on a dark background with blue and white lines surrounding the brain to represent the construction of new connections in the brain.
Defying Dogma: Decentralized Translation in Neurons
Danielle Gerhard, PhD | Sep 8, 2023 | 10+ min read
To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.
Friending Pharma
Tia Ghose | Jun 1, 2009 | 7 min read
By Tia Ghose Friending Pharma With academic/pharma partnerships on the rise, how do academic scientists make the most of the deal? Here are tips from three kinds of collaborations with industry. © James Steinberg As pharma's pipeline dries out, companies are increasingly reaching out to university researchers—and not just for out-of-the-box licensing deals. Over the past three years, Washington University in St. Louis ha
Why Pharma Must Go Hollywood
Liam Bernal | Feb 1, 2007 | 10+ min read
WHY PHARMA MUST GO HOLLYWOOD The answer to stagnating R&D can be found in the creativity of the movie industry.By Liam Bernal The pharmaceutical industry should be a tangible demonstration of the value of the scientific enterprise. Enormous benefits to society should, and generally do, flow from a healthy pharma sector. The transformation of AIDS into a treatable chronic disease is an examp
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Composite image showing genes radiating from tumor cells
Jumping Genes’ Role in Cancer
Diana Kwon | Mar 1, 2023 | 8 min read
Transposons may be key players in how tumors develop and spread, but they also keep cancer at bay in some circumstances.
A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.

Run a Search

ADVERTISEMENT